We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+12.55%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$527M
AUM Growth
+$40.8M
Cap. Flow
-$11M
Cap. Flow %
-2.1%
Top 10 Hldgs %
62.15%
Holding
29
New
4
Increased
12
Reduced
10
Closed
3

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$17.4M
2
ELV icon
Elevance Health
ELV
+$14.3M
3
EXEL icon
Exelixis
EXEL
+$11.9M
4
LLY icon
Eli Lilly
LLY
+$10.8M
5
IPXL
Impax Laboratories, Inc.
IPXL
+$7.62M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$17.7M
2
STJ
St Jude Medical
STJ
+$15.4M
3
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$14.4M
4
MRK icon
Merck
MRK
+$10.4M
5
BMY icon
Bristol-Myers Squibb
BMY
+$9.98M

Sector Composition

Rank Sector Weight
1 Healthcare 98.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$72M 13.68%
914,920
+143,530
+19% +$10.8M
BAX icon
2
Baxter International
BAX
$11.7B
$48.8M 9.26%
1,078,943
-138,887
-11% -$6.09M
BSX icon
3
Boston Scientific
BSX
$65.4B
$33M 6.27%
1,412,170
-354,080
-20% -$7.66M
RVTY icon
4
Revvity
RVTY
$12.3B
$28.5M 5.41%
543,710
+44,680
+9% +$2.35M
SHPG
5
DELISTED
Shire pic
SHPG
$28.1M 5.33%
152,386
+16,706
+12% +$3.02M
IART icon
6
Integra LifeSciences
IART
$1.5B
$26.3M 4.99%
659,314
+56,400
+9% +$2.03M
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$123B
$24M 4.56%
279,083
+70,840
+34% +$6.12M
BIIB icon
8
Biogen
BIIB
$30.4B
$23.4M 4.44%
96,690
+14,780
+18% +$3.9M
IRWD icon
9
Ironwood Pharmaceuticals
IRWD
$635M
$23.1M 4.39%
2,112,625
-856,563
-29% -$8.37M
STJ
10
DELISTED
St Jude Medical
STJ
$20.1M 3.82%
258,214
-215,300
-45% -$15.4M
PDCO
11
DELISTED
Patterson Companies, Inc.
PDCO
$20M 3.79%
416,844
+85,580
+26% +$3.94M
MASI
12
DELISTED
Masimo
MASI
$18.5M 3.51%
352,053
+33,590
+11% +$1.58M
BIO icon
13
Bio-Rad Laboratories Class A
BIO
$8.15B
$18.5M 3.51%
129,124
-3,640
-3% -$519K
ABT icon
14
Abbott
ABT
$175B
$17.1M 3.26%
+436,200
New +$17.4M
EXEL icon
15
Exelixis
EXEL
$14.1B
$16.1M 3.05%
+2,059,833
New +$11.9M
MCK icon
16
McKesson
MCK
$98.5B
$14.7M 2.8%
79,020
-9,620
-11% -$1.69M
MRK icon
17
Merck
MRK
$315B
$14.3M 2.71%
259,537
-195,463
-43% -$10.4M
CI icon
18
Cigna
CI
$74.5B
$14.1M 2.67%
109,870
+10,260
+10% +$1.35M
BMY icon
19
Bristol-Myers Squibb
BMY
$124B
$13.8M 2.62%
187,500
-141,240
-43% -$9.98M
ELV icon
20
Elevance Health
ELV
$80.9B
$13.7M 2.6%
+104,300
New +$14.3M
MNTA
21
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$9.88M 1.88%
914,979
+134,666
+17% +$1.39M
UTHR icon
22
United Therapeutics
UTHR
$22.7B
$8.6M 1.63%
81,224
+21,020
+35% +$2.34M
ACH
23
Accendra Health
ACH
$266M
$7.56M 1.44%
202,342
-18,910
-9% -$711K
IPXL
24
DELISTED
Impax Laboratories, Inc.
IPXL
$6.74M 1.28%
+233,934
New +$7.62M
THC icon
25
Tenet Healthcare
THC
$16.8B
$5.4M 1.02%
195,300
+16,810
+9% +$497K
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2016 Portfolio in Review

As of Q2 2016, Sector Gamma AS held 29 positions worth $527M, up 8.4% from $486M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sector Gamma AS's Q2 2016 filing shows 4 new, 12 increased, 10 reduced and 3 closed positions. Its largest new stake was Abbott: 436,200 shares worth $17.1M. The largest sale was MEDIVATION, INC., an estimated $17.7M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 92% a quarter earlier.

  • Sector Gamma AS's largest Q2 2016 buy was Abbott: 436,200 shares worth $17.1M.
  • Sector Gamma AS added most to Eli Lilly in Q2 2016, an estimated $10.8M increase.
  • Sector Gamma AS's biggest Q2 2016 reduction was St Jude Medical, cutting an estimated $15.4M.
  • Sector Gamma AS fully exited MEDIVATION, INC. in Q2 2016, selling an estimated $17.7M.
  • Sector Gamma AS's ten largest holdings make up 62% of its $527M portfolio in Q2 2016.
  • Sector Gamma AS opened 4 new positions and closed 3 in Q2 2016.
  • Sector Gamma AS's portfolio value rose 8.4% quarter-over-quarter to $527M.

Based on Sector Gamma AS's 13F filing for Q2 2016, filed 11 Aug 2016.